Aprea Therapeutics, Inc. (APRE)
NASDAQ: APRE · Real-Time Price · USD
0.6720
-0.0180 (-2.61%)
Aug 18, 2026, 11:08 AM EDT - Market open
Aprea Therapeutics Market Cap
Aprea Therapeutics has a market cap or net worth of $8.46 million as of August 18, 2026. Its market cap has decreased by -14.05% in one year.
Market Cap
8.46M
Enterprise Value
-32.77M
1-Year Change
-14.05%
Ranking
Category
Stock Price
$0.67
ChartMarket Cap Chart
Since May 27, 2022, Aprea Therapeutics's market cap has decreased from $18.94M to $8.46M, a decrease of -55.31%. That is a compound annual growth rate of -17.34%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 8.46M | 41.83% |
| Dec 31, 2025 | 5.97M | -66.64% |
| Dec 31, 2024 | 17.88M | 1.81% |
| Dec 29, 2023 | 17.56M | 0.11% |
| Dec 30, 2022 | 17.54M | -7.36% |
| May 27, 2022 | 18.94M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MetaVia | 9.75M |
| Lisata Therapeutics | 9.73M |
| Immuron | 8.99M |
| Imunon | 8.98M |
| BioVie | 8.82M |
| Exicure | 8.80M |
| Soligenix | 8.30M |
| Traws Pharma | 8.22M |